Why is Syncom Formul. falling/rising?

As of 24-Sep, Syncom Formulations (India) Ltd is experiencing a decline in its stock price, currently at 17.19, which reflects a decrease of 0.18 or 1.04%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 4.87% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Despite the company reporting positive results over the last five consecutive quarters, including significant growth in PAT and net sales, it faces challenges with long-term growth, as evidenced by a substantial decline in net sales and operating profit over the past five years. The stock's high valuation relative to its peers and the lack of domestic mutual fund investment further contribute to its downward pressure.
In the broader market context, Syncom Formulations has underperformed compared to the benchmark, with a one-week return of -4.61% against the Sensex's -1.18%. Over the past year, the stock has generated a return of -20.82%, significantly worse than the BSE500's decline of -5.32%. This stark contrast indicates that while the overall market has faced challenges, Syncom Formulations' performance has been particularly weak, leading to a lack of investor confidence and participation, as reflected in the declining delivery volume.